MYCO-004

MYCO-004
Clinical data
Other namesMYCO004
Routes of
administration		Transdermal (patch)[1]
Drug classSerotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen

MYCO-004 is a patch-delivered psychedelic tryptamine which is under development for the treatment of psychiatric disorders.[2][3][1] It is anticipated to allow for precision dosing and to have a short duration of approximately 2 hours.[4] The drug is being developed by Mydecine.[2][3] As of December 2021, it is in preclinical research for psychiatric disorders.[2][3] The exact chemical structure of MYCO-004 does not yet seem to have been disclosed.[2]

See also

References

  1. ^ a b Psychedelic Alpha (10 January 2022). "Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds". Psychedelic Alpha. Retrieved 29 January 2025. The Company's AI program has already led to identifying promising enhancements to psilocybin and psilocin which they have included in their recent patent application around MYCO-004, which directly addresses further precision in delivery control and shelf stabilization through a dermal route of administration.
  2. ^ a b c d "MYCO 004". AdisInsight. 15 December 2021. Retrieved 29 January 2025.
  3. ^ a b c "Delving into the Latest Updates on MYCO-004 with Synapse". Synapse. 23 January 2025. Retrieved 29 January 2025.
  4. ^ Psychedelic Alpha (24 June 2021). "Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004". Psychedelic Alpha. Retrieved 29 January 2025.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.